Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$848M |
| 2 |
Tesla
TSLA
|
+$759M |
| 3 |
Home Depot
HD
|
+$653M |
| 4 |
Meta Platforms (Facebook)
META
|
+$567M |
| 5 |
Wells Fargo
WFC
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$786M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
+$409M |
| 3 |
Micron Technology
MU
|
+$379M |
| 4 |
AT&T
T
|
+$372M |
| 5 |
Medtronic
MDT
|
+$370M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.69% |
| 2 | Technology | 14.95% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Consumer Staples | 10.7% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Amplify Energy
AMPY
$166M
| $2.97M | ﹤0.01% |
540,500
+410,700
| +316% | +$1.9M |
|
1927
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.48B
| $2.97M | ﹤0.01% |
29,184
+23,574
| +420% | +$2.48M |
|
1928
LCNB Corp
LCNB
$282M
| $2.97M | ﹤0.01% |
169,116
+10,600
| +7% | +$202K |
|
1929
Trinity Industries
TRN
$2.5B
| $2.96M | ﹤0.01% |
86,300
+72,100
| +508% | +$2.22M |
|
|
SRRA
1930
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $2.96M | ﹤0.01% |
92,474
-18,561
| -17% | -$533K |
|
|
PINE
1931
Alpine Income Property Trust
PINE
$335M
| $2.96M | ﹤0.01% |
157,504
+18,104
| +13% | +$348K |
|
1932
Sylvamo
SLVM
$1.52B
| $2.96M | ﹤0.01% |
88,780
+39,880
| +82% | +$1.32M |
|
1933
Euronet Worldwide
EEFT
$2.8B
| $2.95M | ﹤0.01% |
22,700
-243,745
| -91% | -$30.9M |
|
1934
Glaukos
GKOS
$10.1B
| $2.95M | ﹤0.01% |
51,092
-111,400
| -69% | -$5.89M |
|
1935
Reading International Class A
RDI
$32.7M
| $2.95M | ﹤0.01% |
689,090
-18,200
| -3% | -$79.2K |
|
|
CLVS
1936
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.95M | ﹤0.01% |
1,459,900
+849,500
| +139% | +$1.67M |
|
1937
Arcos Dorados Holdings
ARCO
$1.75B
| $2.95M | ﹤0.01% |
+362,334
| New | +$2.5M |
|
|
MYOV
1938
DELISTED
Myovant Sciences Ltd.
MYOV
| $2.95M | ﹤0.01% |
221,200
+65,500
| +42% | +$878K |
|
1939
iRhythm Holdings
IRTC
$4.1B
| $2.94M | ﹤0.01% |
+18,700
| New | +$2.4M |
|
|
NETI
1940
DELISTED
Eneti Inc.
NETI
| $2.94M | ﹤0.01% |
463,145
+168,787
| +57% | +$1.15M |
|
1941
Liberty Media Series C
FWONK
$24.5B
| $2.94M | ﹤0.01% |
43,510
+39,683
| +1,037% | +$2.36M |
|
1942
GSI Technology
GSIT
$233M
| $2.94M | ﹤0.01% |
766,424
-104,099
| -12% | -$447K |
|
|
SBOW
1943
DELISTED
SilverBow Resources, Inc.
SBOW
| $2.93M | ﹤0.01% |
91,576
-39,700
| -30% | -$1.02M |
|
|
CPRX
1944
DELISTED
Catalyst Pharmaceutical
CPRX
| $2.93M | ﹤0.01% |
353,112
-69,774
| -16% | -$493K |
|
|
CFMS
1945
DELISTED
Conformis, Inc. Common Stock
CFMS
| $2.93M | ﹤0.01% |
187,618
-53,938
| -22% | -$886K |
|
|
GOCO
1946
DELISTED
GoHealth
GOCO
| $2.91M | ﹤0.01% |
+164,447
| New | +$5.12M |
|
1947
Miller Industries
MLR
$572M
| $2.91M | ﹤0.01% |
103,200
+5,500
| +6% | +$169K |
|
1948
Viking Therapeutics
VKTX
$3.8B
| $2.9M | ﹤0.01% |
967,349
+724,476
| +298% | +$2.6M |
|
|
CTHR
1949
DELISTED
Charles & Colvard Ltd
CTHR
| $2.9M | ﹤0.01% |
184,710
-22,507
| -11% | -$462K |
|
1950
OSI Systems
OSIS
$3.9B
| $2.89M | ﹤0.01% |
34,000
-16,900
| -33% | -$1.42M |
|
Similar funds
Renaissance Technologies's Q1 2022 Portfolio in Review
As of Q1 2022, Renaissance Technologies held 4,686 positions worth $85.2B, up 6% from $80.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies deployed $8.98B of net new capital in Q1 2022, opening 822 new positions and adding to 1,556 existing holdings. Its largest new stake was Advanced Micro Devices: 7,107,290 shares worth $777M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $409M trimmed.
- Renaissance Technologies's largest Q1 2022 buy was Advanced Micro Devices: 7,107,290 shares worth $777M.
- Renaissance Technologies added most to Tesla in Q1 2022, an estimated $759M increase.
- Renaissance Technologies's biggest Q1 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $409M.
- Renaissance Technologies fully exited Microsoft in Q1 2022, selling an estimated $786M.
- Renaissance Technologies's ten largest holdings make up 12% of its $85.2B portfolio in Q1 2022.
- Renaissance Technologies opened 822 new positions and closed 650 in Q1 2022.
- Renaissance Technologies's portfolio value rose 6% quarter-over-quarter to $85.2B.
Based on Renaissance Technologies's 13F filing for Q1 2022, filed 13 May 2022.